Gene therapy for RPE65-mediated inherited retinal dystrophy completes phase 3

Lancet. 2017 Aug 26;390(10097):823-824. doi: 10.1016/S0140-6736(17)31622-7. Epub 2017 Jul 14.
No abstract available

Publication types

  • Comment

MeSH terms

  • Genetic Therapy
  • Humans
  • Retinal Dystrophies*
  • cis-trans-Isomerases

Substances

  • cis-trans-Isomerases